下调Notch信号可抵消骨髓增殖性肿瘤中KrasG12D诱导的ERK激活与氧化磷酸化
该研究在小鼠骨髓增殖性肿瘤(MPN)模型中揭示Notch信号新的致癌功能:通过DNMAML表达或Pofut1缺失下调造血细胞Notch信号,可以细胞自主方式显著阻断KrasG12D小鼠MPN发展。机制上,抑制Notch信号上调Dusp1、下调细胞因子诱导的ERK激活,并重编程线粒体代谢;联合抑制MEK/ERK通路与氧化磷酸化可有效抑制人和小鼠白血病细胞体外生长。
要点
- 在KrasG12D小鼠中,通过DNMAML或Pofut1缺失下调Notch信号可显著阻断MPN发展。
- 抑制Notch信号上调Dusp1、下调ERK激活并重编程线粒体代谢。
- 联合抑制MEK/ERK通路与氧化磷酸化可有效抑制人和小鼠白血病细胞体外生长。
核心结论
- Notch信号在致癌Kras诱导的MPN中具有新的致癌功能,下调Notch可抵消KrasG12D诱导的ERK激活与氧化磷酸化。
- 研究为在致癌Ras驱动的髓系白血病中同时靶向ERK信号和异常代谢提供了强有力依据。
研究设计与样本
- 研究采用KrasG12D小鼠MPN模型,通过DNMAML表达或Pofut1缺失在造血细胞中下调Notch信号。
- 机制研究检测Dusp1表达、细胞因子诱导的ERK激活及线粒体代谢,并进行体外联合抑制实验。
主要发现
- 通过DNMAML表达或Pofut1缺失下调造血细胞Notch信号,以细胞自主方式显著阻断KrasG12D小鼠MPN发展。
- 抑制Notch信号上调Dusp1(使p-ERK失活的双磷酸酶),并下调KrasG12D细胞中细胞因子诱导的ERK激活。
- KrasG12D细胞线粒体代谢显著增强,DNMAML使其显著重编程至接近对照细胞水平。
- KrasG12D小鼠细胞增殖及扩大的髓系 compartment 显著减少。
- 联合抑制MEK/ERK通路与线粒体氧化磷酸化有效抑制人和小鼠白血病细胞体外生长。
关键数值与推荐
- KrasG12D细胞线粒体代谢显著增强,DNMAML重编程后接近对照细胞。
- 联合抑制MEK/ERK通路与线粒体氧化磷酸化有效抑制人和小鼠白血病细胞体外生长。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Notch signaling pathway contributes to the pathogenesis of a wide spectrum of human cancers, including hematopoietic malignancies. Its functions are highly dependent on the specific cellular context. Gain-of-function NOTCH1 mutations are prevalent in human T-cell leukemia, while loss of Notch signaling is reported in myeloid leukemias. Here, we report a novel oncogenic function of Notch signaling in oncogenic Kras-induced myeloproliferative neoplasm (MPN). We find that downregulation of Notch signaling in hematopoietic cells via DNMAML expression or Pofut1 deletion significantly blocks MPN development in KrasG12D mice in a cell-autonomous manner. Further mechanistic studies indicate that inhibition of Notch signaling upregulates Dusp1, a dual phosphatase that inactivates p-ERK, and downregulates cytokine-evoked ERK activation in KrasG12D cells. Moreover, mitochondrial metabolism is greatly enhanced in KrasG12D cells but significantly reprogrammed by DNMAML close to that in control cells. Consequently, cell proliferation and expanded myeloid compartment in KrasG12D mice are significantly reduced. Consistent with these findings, combined inhibition of the MEK/ERK pathway and mitochondrial oxidative phosphorylation effectively inhibited the growth of human and mouse leukemia cells in vitro. Our study provides a strong rational to target both ERK signaling and aberrant metabolism in oncogenic Ras-driven myeloid leukemia.
引用
- Kong G, You X, Wen Z, et al. Downregulating Notch counteracts KrasG12D-induced ERK activation and oxidative phosphorylation in myeloproliferative neoplasm. Leukemia. 2018. PMID: 30206308. doi:10.1038/s41375-018-0248-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。